TY - JOUR PY - 2017// TI - Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms JO - Scientific reports A1 - Carhart-Harris, Robin L. A1 - Roseman, Leor A1 - Bolstridge, Mark A1 - Demetriou, Lysia A1 - Pannekoek, J. Nienke A1 - Wall, Matthew B. A1 - Tanner, Mark A1 - Kaelen, Mendel A1 - McGonigle, John A1 - Murphy, Kevin A1 - Leech, Robert A1 - Curran, H. Valerie A1 - Nutt, David J. SP - e13187 EP - e13187 VL - 7 IS - 1 N2 - Psilocybin with psychological support is showing promise as a treatment model in psychiatry but its therapeutic mechanisms are poorly understood. Here, cerebral blood flow (CBF) and blood oxygen-level dependent (BOLD) resting-state functional connectivity (RSFC) were measured with functional magnetic resonance imaging (fMRI) before and after treatment with psilocybin (serotonin agonist) for treatment-resistant depression (TRD). Quality pre and post treatment fMRI data were collected from 16 of 19 patients. Decreased depressive symptoms were observed in all 19 patients at 1-week post-treatment and 47% met criteria for response at 5 weeks. Whole-brain analyses revealed post-treatment decreases in CBF in the temporal cortex, including the amygdala. Decreased amygdala CBF correlated with reduced depressive symptoms. Focusing on a priori selected circuitry for RSFC analyses, increased RSFC was observed within the default-mode network (DMN) post-treatment. Increased ventromedial prefrontal cortex-bilateral inferior lateral parietal cortex RSFC was predictive of treatment response at 5-weeks, as was decreased parahippocampal-prefrontal cortex RSFC. These data fill an important knowledge gap regarding the post-treatment brain effects of psilocybin, and are the first in depressed patients. The post-treatment brain changes are different to previously observed acute effects of psilocybin and other 'psychedelics' yet were related to clinical outcomes. A 'reset' therapeutic mechanism is proposed.

Language: en

LA - en SN - 2045-2322 UR - http://dx.doi.org/10.1038/s41598-017-13282-7 ID - ref1 ER -